TrialHaematologica2024

Efficacy and safety of daratumumab plus bortezomib and dexamethasone in newly diagnosed Mayo 2004 stage IIIA or IIIB light-chain amyloidosis: a prospective phase II study.

Kai-Ni Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.